OTO-104 for Meniere's Disease
Public ClinicalTrials.gov record NCT01084525. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 1B Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety of OTO-104 in subjects with unilateral Meniere's disease. The effectiveness of OTO-104 to reduce the symptoms of Meniere's disease will also be evaluated.
Study identification
- NCT ID
- NCT01084525
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 44 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2010 (Type not available)
- Primary completion
- Mar 2011 (Actual)
- Completion
- Apr 2011 (Actual)
- Last update posted
- Jun 8, 2011
2010 – 2011
United States locations
- U.S. sites
- 15
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| House Ear Institute | Los Angeles | California | 90057 | — |
| University of California, San Diego | San Diego | California | 92037-0970 | — |
| Colorado Otolaryngology Associates | Colorado Springs | Colorado | 80909 | — |
| Silverstein Institute | Sarasota | Florida | 34239 | — |
| Northwestern University, Feinberg School of Medicine, Otolaryngology | Chicago | Illinois | 60611 | — |
| Mass Eye & Ear Infirmary | Boston | Massachusetts | 02114 | — |
| University of Michigan Hospitals, Dept. of Otolaryngology | Ann Arbor | Michigan | 48109 | — |
| Michigan Ear Institute | Farmington Hills | Michigan | 48334 | — |
| St Louis University | St Louis | Missouri | 63110 | — |
| New York Eye and Ear Infirmary | New York | New York | 10003 | — |
| Crescent Medical Research | Salisbury | North Carolina | 28144 | — |
| Wilmington Medical Research | Wilmington | North Carolina | 28401 | — |
| Piedmont Medical Research | Winston-Salem | North Carolina | 27103 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University Of Texas, Southwestern Medical Center | Dallas | Texas | 75390 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01084525, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 8, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01084525 live on ClinicalTrials.gov.